Astepro (Meda Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Astepro drug offered from Meda Pharmaceuticals Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Azelastine Hydrochloride |
SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-10-12 |
END MARKETING DATE: | 0000-00-00 |
Astepro HUMAN PRESCRIPTION DRUG Details:
Item Description | Astepro from Meda Pharmaceuticals Inc. |
LABELER NAME: | Meda Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 205.5(ug/1) |
START MARKETING DATE: | 2009-10-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0037-0243_98263b8c-1476-4df0-b663-f5cb946b2fd8 |
PRODUCT NDC: | 0037-0243 |
APPLICATION NUMBER: | NDA022203 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: